Ben Hirschler
Articles RSSArticles
Blame game slows growth of personalized medicine
LONDON (Reuters) - Expectation has been building for a decade that an era of personalized medicine will transform the global drugs business, but the reality is a slow start and an angry blame game between scientists, marketers and regulators. Full Article
UK cost body again rejects Roche bowel cancer drug
LONDON, Nov 24 (Reuters) - Britain's healthcare cost-effectiveness watchdog has again rejected Roche's <ROG.VX> drug Avastin as a treatment for bowel cancer, saying it is too expensive. Full Article
UPDATE 1-Glaxo temporarily withdraws Avodart cancer filing
* Says needs to update data, unrelated to safety or efficacy Full Article
UPDATE 1-EU body backs single dose for 2 H1N1 flu vaccines
* EMEA says single dose of Glaxo, Novartis vaccines enough Full Article
UPDATE 3-U.S. panel rejects Xolair asthma drug for children
* FDA advisory panel votes 10-4 against approval of Xolair Full Article
UPDATE 3-U.S. panel rejects Xolair asthma drug for children
* FDA advisory panel votes 10-4 against approval of Xolair Full Article
UPDATE 3-U.S. panel rejects Xolair asthma drug for children
* FDA advisory panel votes 10-4 against approval of Xolair Full Article
FDA warns heartburn drugs interfere with Plavix
WASHINGTON (Reuters) - Common heartburn pills Prilosec and Nexium cut the blood-thinning effect of Sanofi-Aventis SA's and Bristol-Myers Squibb Co's heart drug Plavix, U.S. officials warned on Tuesday. Full Article
Icelandic gene pioneer Decode files for bankruptcy
WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Full Article
UPDATE 3-Icelandic gene pioneer Decode files for bankruptcy
* Lists assets of $69.9 million, debt of $313.9 million Full Article
